Rankings
▼
Calendar
RYTM FY 2021 Earnings — Rhythm Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
RYTM
Rhythm Pharmaceuticals, Inc.
$6B
FY 2021 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$3M
Gross Profit
$3M
81.0% margin
Operating Income
-$170M
-5391.9% margin
Net Income
-$70M
-2207.1% margin
EPS (Diluted)
$-1.37
Cash Flow
Operating Cash Flow
-$146M
Free Cash Flow
-$151M
Stock-Based Comp.
$21M
Balance Sheet
Total Assets
$330M
Total Liabilities
$45M
Stockholders' Equity
$284M
Cash & Equivalents
$59M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$3M
$0
—
Gross Profit
$3M
-$690,000
+470.3%
Operating Income
-$170M
-$137M
-24.5%
Net Income
-$70M
-$131M
+46.8%
← Q4 2020
All Quarters
Q1 2021 →